Engohang-Ndong Jean, Baillat David, Aumercier Marc, Bellefontaine Flore, Besra Gurdyal S, Locht Camille, Baulard Alain R
INSERM-U447, Institut de Biologie de Lille - Institut Pasteur de Lille, 1 rue du Professeur Calmette, BP 245, 59019 Lille Cedex, France.
Mol Microbiol. 2004 Jan;51(1):175-88. doi: 10.1046/j.1365-2958.2003.03809.x.
Ethionamide (ETH) is an important second-line antitubercular drug used for the treatment of patients infected with multidrug-resistant Mycobacterium tuberculosis. Although ETH is a structural analogue of isoniazid, only little cross-resistance to these two drugs is observed among clinical isolates. Both isoniazid and ETH are pro-drugs that need to be activated by mycobacterial enzymes to exert their antimicrobial activity. We have recently identified two M. tuberculosis genes, Rv3854c (ethA) and Rv3855 (ethR), involved in resistance to ETH. ethA encodes a protein that belongs to the Flavin-containing monooxygenase family catalysing the activation of ETH. We show here that ethR, which encodes a repressor belonging to the TetR/CamR family of transcriptional regulators, negatively regulates the expression of ethA. By the insertion of the ethA promoter region upstream of the lacZ reporter gene, overexpression of ethR in trans was found to cause a strong inhibition of ethA expression, independently of the presence of ETH in the culture media. Electrophoretic mobility shift assays indicated that EthR interacts directly with the ethA promoter region. This interaction was confirmed by DNA footprinting analysis, which, in addition, identified the EthR-binding region. Unlike other TetR/CamR members, which typically bind 15 bp operators, EthR recognises an unusually long 55 bp region suggesting multimerization of the repressor on its operator. Identification by primer-extension of the ethA transcriptional start site indicated that it is located within the EthR-binding region. Taken together, bacterial two-hybrid experiments and gel filtration assays suggested a dimerization of EthR in the absence of its operator. In contrast, surface plasmon resonance analyses showed that eight EthR molecules bind cooperatively to the 55 bp operator, which represents a novel repression mechanism for a TetR/CamR member.
乙硫异烟胺(ETH)是一种重要的二线抗结核药物,用于治疗多重耐药结核分枝杆菌感染的患者。尽管ETH是异烟肼的结构类似物,但在临床分离株中仅观察到这两种药物之间很少有交叉耐药性。异烟肼和ETH都是前体药物,需要被分枝杆菌酶激活才能发挥其抗菌活性。我们最近鉴定出两个与ETH耐药相关的结核分枝杆菌基因,Rv3854c(ethA)和Rv3855(ethR)。ethA编码一种属于含黄素单加氧酶家族的蛋白质,催化ETH的激活。我们在此表明,编码属于转录调节因子TetR/CamR家族的阻遏物的ethR,对ethA的表达起负调节作用。通过将ethA启动子区域插入lacZ报告基因上游,发现反式表达的ethR会强烈抑制ethA的表达,而与培养基中是否存在ETH无关。电泳迁移率变动分析表明EthR直接与ethA启动子区域相互作用。DNA足迹分析证实了这种相互作用,此外还确定了EthR结合区域。与其他通常结合15 bp操纵子的TetR/CamR成员不同,EthR识别一个异常长的55 bp区域,这表明阻遏物在其操纵子上发生了多聚化。通过引物延伸鉴定ethA转录起始位点表明它位于EthR结合区域内。综合来看,细菌双杂交实验和凝胶过滤分析表明EthR在没有其操纵子的情况下会发生二聚化。相比之下,表面等离子体共振分析表明八个EthR分子协同结合到55 bp操纵子上,这代表了TetR/CamR成员的一种新型抑制机制。